Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Amazon
AMZN
|
+$511M |
| 2 |
Apple
AAPL
|
+$502M |
| 3 |
McDonald's
MCD
|
+$485M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$425M |
| 5 |
Home Depot
HD
|
+$422M |
Top Sells
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$657M |
| 2 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$320M |
| 3 |
Cisco
CSCO
|
+$144M |
| 4 |
Meta Platforms (Facebook)
META
|
+$135M |
| 5 |
Eli Lilly
LLY
|
+$108M |
Sector Composition
| 1 | Technology | 18.35% |
| 2 | Financials | 14.85% |
| 3 | Healthcare | 14.2% |
| 4 | Consumer Discretionary | 10.44% |
| 5 | Industrials | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
2051
DELISTED
Revance Therapeutics, Inc.
RVNC
| $7.7M | ﹤0.01% |
488,347
+102,529
| +27% | +$1.62M |
|
2052
John B. Sanfilippo & Son
JBSS
$737M
| $7.68M | ﹤0.01% |
106,807
+8,180
| +8% | +$588K |
|
2053
Griffon
GFF
$3.61B
| $7.67M | ﹤0.01% |
414,920
+50,035
| +14% | +$925K |
|
|
HSKA
2054
DELISTED
Heska Corp
HSKA
| $7.65M | ﹤0.01% |
89,923
-2,811
| -3% | -$239K |
|
2055
Stellar Bancorp
STEL
$1.61B
| $7.64M | ﹤0.01% |
235,424
+10,658
| +5% | +$346K |
|
|
STFC
2056
DELISTED
State Auto Financial Corp
STFC
| $7.64M | ﹤0.01% |
232,139
+30,550
| +15% | +$1.01M |
|
|
EGRX
2057
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $7.64M | ﹤0.01% |
151,309
+19,266
| +15% | +$973K |
|
2058
DXP Enterprises
DXPE
$1.85B
| $7.63M | ﹤0.01% |
196,015
+14,459
| +8% | +$563K |
|
2059
MasterCraft Boat Holdings
MCFT
$362M
| $7.62M | ﹤0.01% |
337,828
+1,943
| +0.6% | +$43.8K |
|
|
CHCT
2060
Community Healthcare Trust
CHCT
$445M
| $7.61M | ﹤0.01% |
211,931
+18,186
| +9% | +$653K |
|
|
ACOR
2061
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $7.61M | ﹤0.01% |
4,770
+279
| +6% | +$445K |
|
2062
Addus HomeCare
ADUS
$2.03B
| $7.59M | ﹤0.01% |
119,356
+7,537
| +7% | +$479K |
|
|
PDLI
2063
DELISTED
PDL BioPharma, Inc.
PDLI
| $7.53M | ﹤0.01% |
2,024,735
+114,167
| +6% | +$425K |
|
2064
Bausch Health
BHC
$2.68B
| $7.52M | ﹤0.01% |
307,317
+49,131
| +19% | +$1.2M |
|
2065
Century Communities
CCS
$2B
| $7.51M | ﹤0.01% |
313,176
+23,955
| +8% | +$574K |
|
|
BFS
2066
Saul Centers
BFS
$785M
| $7.49M | ﹤0.01% |
145,911
-20,857
| -13% | -$1.07M |
|
|
IPHS
2067
DELISTED
Innophos Holdings, Inc.
IPHS
| $7.49M | ﹤0.01% |
248,575
+24,725
| +11% | +$745K |
|
2068
Flushing Financial
FFIC
$476M
| $7.49M | ﹤0.01% |
341,449
+18,256
| +6% | +$400K |
|
2069
OneSpan
OSPN
$588M
| $7.49M | ﹤0.01% |
389,532
+39,574
| +11% | +$761K |
|
2070
TTEC Holdings
TTEC
$173M
| $7.48M | ﹤0.01% |
206,544
+8,752
| +4% | +$317K |
|
|
NBIS
2071
Nebius Group N.V. Class A Ordinary Shares
NBIS
$21.6B
| $7.48M | ﹤0.01% |
217,837
+6,349
| +3% | +$218K |
|
2072
ANI Pharmaceuticals
ANIP
$2.12B
| $7.47M | ﹤0.01% |
105,961
+8,502
| +9% | +$600K |
|
|
BPYU
2073
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $7.47M | ﹤0.01% |
366,145
-19,363
| -5% | -$395K |
|
2074
TG Therapeutics
TGTX
$5.1B
| $7.46M | ﹤0.01% |
928,149
+172,944
| +23% | +$1.39M |
|
|
ITCI
2075
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $7.46M | ﹤0.01% |
612,614
+88,153
| +17% | +$1.07M |
|